Close Menu

NEW YORK (GenomeWeb) – Singapore-based cancer detection firm Ark said today that it has raised $40 million in a Series A investment led by shareholders of Venturecraft and backed by Gaorong Capital (formerly Banyan Capital).

The company is the result of a merger between Venturecraft and MiRxes, a technology firm that was spun out of Singapore's Agency for Science, Technology and Research (A*STAR) in 2014.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Newsweek discusses the privacy issues raised by digital medicine.

A group of statisticians wants to eliminate researchers' reliance on 'statistical significance,' according to NPR.

In Nature this week: genetic analysis of Anatolian farmers, cotton genome analysis, and more.

Matt Hancock, the UK health secretary, is calling for the swift rollout of predictive genetic tests, the Guardian reports.